Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITAN: Ixabepilone vs Paclitaxel in Early-Stage TNBC
NCT00789581Phase 3Completed
- Sponsor
- SCRI Development Innovations
- Start
- Dec 2008
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ixabepilone in triple-negative breast cancer (TNBC), sponsored by SCRI Development Innovations. Started Dec 2008; status: completed.
02
Drugs
ixabepilone
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT00789581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789581.